Effectiveness of a High-intensity Interval Exercise Program in People With Alzheimer's
NCT05691842, Not applicable, Unknown, University of Valencia
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effectiveness of a High-intensity Interval Exercise Program in People With Alzheimer's | ClinicalTrials.gov |
| NCT number | NCT05691842 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 66 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | University of Valencia | ClinicalTrials.gov |
| Conditions | Alzheimer Disease | ClinicalTrials.gov |
| Interventions | HIIT intervention, Dual task intervention | ClinicalTrials.gov |
| First posted | 2023-01-20 | ClinicalTrials.gov |
| Last updated | 2023-01-20 | ClinicalTrials.gov |
Registered outcomes 10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change from baseline cardiorespiratory fitness | At baseline, immediately after the intervention and at 2 month-follow-up | 6 minutes walking test" (6MWT): distance (m) | ClinicalTrials.gov |
| Primary | Change from baseline balance ability | At baseline, post-intervention and at 2 month-follow-up | Star Excursion Balance Test: maximal distance in all directions (cm), 3 times | ClinicalTrials.gov |
| Secondary | Change from baseline lower limb isometric strength | At baseline, immediately after the intervention and at 2 month-follow-up | Lafyette dynamometer: quadriceps, hamstrings, gastrocnemius,tibialis anterior | ClinicalTrials.gov |
| Secondary | Change from baseline lower limb power | At baseline, immediately after the intervention and at 2 month-follow-up | 30 Second Sit to Stand Test: number of times the patient comes to a full standing position in 30 seconds | ClinicalTrials.gov |
| Secondary | Change from baseline Risk of Falling | At baseline, immediately after the intervention and at 2 month-follow-up | Timed up and go: time (in seconds) that a person takes to rise from a chair, walk three meters, turn around 180 degrees, walk back to the chair, and sit down while turning 180 degrees. An older adult who takes ≥12 seconds to complete the TUG is at risk for falling | ClinicalTrials.gov |
| Secondary | Fall frequency | Daily for 12 weeks (the length of the intervention) | Fall diary. The individual is asked to write down how many times he/she falls during a period. | ClinicalTrials.gov |
| Secondary | Change from baseline Fear of falling | At baseline, immediately after the intervention and at 2 month-follow-up | Falls Eficacy Scale International. It is a 16 item questionnaire, useful to the researchers and clinicians interested in fear of falling, with a score ranging from minimum 16 (no concern about falling) to maximum 64 (severe concern about falling) | ClinicalTrials.gov |
| Secondary | Change from baseline Cognitive status | At baseline, immediately after the intervention and at 2 month-follow-up | Mini-Mental State Examination: The Mini-mental state examination is scored on a scale of 0-30 with scores \> 24 interpreted as normal cognitive status. | ClinicalTrials.gov |
| Secondary | Change from baseline Executive function status | At baseline, immediately after the intervention and at 2 month-follow-up | Stroop test: Three scores, as well as an interference score, are generated using the number of items completed on each page, with higher scores reflecting better performance and less interference on reading ability. | ClinicalTrials.gov |
| Secondary | Change from baseline depression levels | At baseline, immediately after the intervention and at 2 month-follow-up | Geriatric Depression Scale (15-item scale): This scale is scored form 0 to 15. A score higher than 5 points suggests depression. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)